Appointment of the Interim CEO to the Board
Rachel Parsonage appointed to Board as Interim CEO following regulatory due diligence.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
9 March 2026 - SkinBioTherapeutics plc, (AIM: SBTX), the life science business focused on skin health, has confirmed the appointment of Rachel Parsonage, Interim CEO to the Board of Directors. Her appointment was subject to normal regulatory due diligence carried out by the Company's Nominated Adviser, which is now complete.
Martin Hunt, Executive Chairman of SkinBioTherapeutics, said:
"Rachel has been in the post of Interim CEO for just a week so far, and already, she has met the majority of the team and is getting under the skin of the business, including building relationships with our key partners. Her deep experience in leading consumer beauty and wellness companies is evident in her approach, and she has a clear plan of what she wants to achieve in the immediate near term. In the meantime, we are waiting for the outcome of the external investigation as well as preparing for the HY results. We will make further announcements on these events in due course."
| Full name: | Rachel Parsonage |
| Age: | 51 |
| Shareholding in SkinBioTherapeutics: | Nil |
| Current directorships held: | Alera Advisory Ltd |
| Directorships held in the previous 5 years: | Knowledge & Merchandising Inc Ltd KMI Brands Ltd KMI Brands Inc |
| Directorships or Shadow Directorships held in companies that have entered administration or insolvency: | This Works Limited [Dissolved 20 April 2011] Knowledge and Merchandising Intellectual Property Limited [Voluntarily dissolved 27 December 2011] Enormous Yes Company Limited [Voluntarily dissolved 9 February 2016] ILK Limited [Voluntarily dissolved 2021 and went into administration on 30 June 2023] |
Thumbnail image
Interim CEO, Rachel Parsonage
Background of Rachel Parsonage
Rachel is a seasoned senior executive with over 25 years' experience leading consumer beauty and wellness businesses through growth and change. She has held CEO and transformational level leadership roles across owned and licensed brand portfolios in both domestic and international markets. She has been involved in financial and business model management, operations and inventory management, and the strengthening of corporate governance. Rachel has also worked closely with boards, founders, lenders and partners to navigate periods of transition.
Currently, Rachel runs her own advisory consultancy, Alera Advisory. Before then, she was at KMI Brands for over 16 years, rising from Managing Director to Chief Executive, where she scaled and stabilised a portfolio of owned and licensed beauty brands. Before then, Rachel was Managing Director at This Works, a premium British aromatherapy and skincare brand with UK and US focus, and previously, she was owner of Vita Management, an independent consultancy. Prior to this, she was General Manager at Pacific Direct, a global hotel manufacturing amenity company providing brand development for hotels working with luxury brands, Elemis, Penhaligons and White Company. Rachel is an alumnus of the Business Growth Programme (BGP), part of Cranfield's Executive Development Programme.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.